Two drugs under development to treat advanced prostate cancer will be tested to combat acute respiratory distress syndrome, the most deadly response to COVID-19 infection. Association...
Common symptoms of 2019 coronavirus disease (COVID-19) are cough, fever, malaise, and loss of odor. Many COVID-19 patients also have gastrointestinal symptoms. This correlates with severe...
The search for antiviral drugs and vaccines that can prevent cell invasion and infection caused by Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) continues as the...
The COVID-19 pandemic infects more than 40 million people worldwide. Despite the high mortality rates seen in inpatients, little is known about the medium- to long-term...
_4fa2881394a143e397cb407def3becae-620x480.jpg "Survivors of COVID-19 may have protective antibodies for 4 months")
A new study by researchers at Harvard Medical School and Massachusetts General Hospital (MGH) aims to determine the duration of severe acute respiratory syndrome coronavirus 2...
An international team of scientists have identified a novel T cell recognition epitope across various proteins of severe acute respiratory syndrome coronavirus 2 in patients recovered...
Recent Comments